The early detection of PCa using PSA results in a large number of negative biopsies and a high proportion of patients diagnosed with clinically low aggressive tumours (over-diagnosis) followed by unnecessary treatment (over-treatment) and morbidity related to complications [14, 15]. This evidence concerns the gene KLK3 and posterior cortical atrophy.